Millennium Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Millennium Management's GMAB Position: Q3 2026 in Review
Millennium Management reduced its Genmab (GMAB) stake by 17% in Q3 2026, selling an estimated $4.87M and leaving 756,496 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #1395.
Millennium Management first reported a position in GMAB in Q3 2019 and has held it in 26 quarters since. The position peaked at $39M in Q4 2022. 333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Millennium Management held 756,496 shares of Genmab worth $27M as of Q3 2026.
- Millennium Management sold 154,108 Genmab shares in Q3 2026, an estimated $4.87M.
- Genmab made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1395 holding.
- Millennium Management first reported a position in Genmab in Q3 2019 and has held it in 26 quarters since.
- Millennium Management's Genmab position peaked at $39M in Q4 2022.
- 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.